1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
Follow Glanzmann Thrombasthenia: new trials by email Literature Review of Glanzmann Thrombasthenia trials Research Report on Glanzmann Thrombasthenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia HMB-001 - Glanzmann Thrombasthenia | Phase 1 / Phase 2 | Active not recruiting | Hemab ApS | 57 | 2022-12-13 | 2026-09-25 |
| Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders Coagulation Factor VIIa variant - Factor VII Deficiency, Glanzmann Thrombasthenia | Phase 1 / Phase 2 | Terminated | Catalyst Biosciences | 19 | 2021-05-17 | 2021-12-21 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases Abatacept - Hurler Syndrome, Fanconi Anemia | Phase 1 | Completed | Emory University | 10 | 2014-01-01 | 2019-12-26 |
Thrombasthenia (3) · Anemia, Aplastic (1) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Chediak-Higashi Syndrome (1) · Dyskeratosis Congenita (1) · Factor VII Deficiency (1) · Fanconi Anemia (1) · Granulomatous Disease, Chronic (1) · Leukocyte adhesion deficiency type 1 (1) · Lymphohistiocytosis, Hemophagocytic (1) · Mucopolysaccharidosis I (1) · Neutropenia, Severe Congenital, Autosomal Recessive 3 (1) · Shwachman-Diamond Syndrome (1) · Wiskott-Aldrich Syndrome (1)
Blood Coagulation Disorders (3) · Blood Coagulation Disorders, Inherited (3) · Blood Platelet Disorders (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemorrhagic Disorders (3) · Albinism (1) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Anemia, Hypoplastic, Congenital (1) · Bone Marrow Diseases (1) · Bone Marrow Failure Disorders (1)
Abatacept (1)
Catalyst Biosciences (1) · Emory University (1) · Hemab ApS (1)
United States (3) · Italy (2) · Belgium (1) · France (1) · India (1) · Netherlands (1) · Russia (1) · Ukraine (1) · United Kingdom (1)
John T Horan, MD (1)